KRAS mutation in secondary malignant histiocytosis arising from low grade follicular lymphoma.
Sarah M ChoiAleodor A AndeaMin WangAmir BehdadLina ShaoYanming ZhangXinyan LuDavid DittmannJuan CastroYi-Hua ChenJuehua GaoPublished in: Diagnostic pathology (2018)
This report highlights genetic alterations, in particular an acquired somatic KRAS mutation, that may occur during transdifferentiation, with additional significance of KRAS mutation as a possible therapeutic target in cases which otherwise would have limited treatment options.
Keyphrases